Analysts Offer Insights on Healthcare Companies: ProSomnus (OSA), Merck & Company (MRK) and Phreesia (PHR)
TipRanksMar 27 08:30 ET
Craig-Hallum Reaffirms Their Hold Rating on ProSomnus (OSA)
TipRanksMar 18 08:36 ET
ProSomnus Analyst Ratings
BenzingaJan 22 14:38 ET
Craig-Hallum Downgrades ProSomnus to Hold, Announces $1 Price Target
BenzingaNov 10, 2023 11:27 ET
ProSomnus Analyst Ratings
BenzingaNov 10, 2023 11:26 ET
ResMed Upgraded at JPMorgan; Says GLP-1 Threat Overdone
Seeking AlphaOct 9, 2023 15:19 ET
Roth MKM Maintains Buy on ProSomnus, Lowers Price Target to $4
BenzingaSep 26, 2023 09:47 ET
ProSomnus Analyst Ratings
BenzingaSep 26, 2023 09:46 ET
Craig-Hallum Sticks to Their Buy Rating for ProSomnus (OSA)
TipRanksMay 8, 2023 09:12 ET
Roth MKM Initiates Coverage On ProSomnus With Buy Rating, Announces Price Target of $9
BenzingaApr 18, 2023 05:37 ET
Analysts Offer Insights on Healthcare Companies: Danaher (DHR) and ProSomnus (OSA)
TipRanksApr 18, 2023 03:57 ET
Craig-Hallum Initiates Coverage On ProSomnus With Buy Rating, Announces Price Target of $10
BenzingaApr 3, 2023 09:22 ET
ProSomnus (OSA) Receives a New Rating From Craig-Hallum
TipRanksApr 3, 2023 08:41 ET
No Data
No Data